TTK Healthcare Limited (IN:TTKHLTCARE)

:TTKHLTCARE

TTKHLTCARE

TTK Healthcare Limited

RESEARCH TOOLSreports

Want to see IN:TTKHLTCARE full AI Analyst Report?

TTK Healthcare Limited (TTKHLTCARE) Price & Analysis

0 Followers

TTKHLTCARE Stock Chart & Stats

₹1029.00

₹5.50(0.40%)

At close: Jan 08 4:00 PM EST

₹1029.00

₹5.50(0.40%)

Day’s Range― - ―

52-Week Range₹737.00 - ₹1,402.00

Previous CloseN/A

Volume1.55K

Average Volume (3M)82.00

Market Cap

₹12.68B

Enterprise Value₹6.88B

Total Cash (Recent Filing)₹6.01B

Total Debt (Recent Filing)₹285.86M

Price to Earnings (P/E)19.2

Beta0.88

Next Earnings

Jul 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.95%

Share Statistics

EPS (TTM)46.90

Shares Outstanding14,130,333

10 Day Avg. Volume50

30 Day Avg. Volume82

Financial Highlights & Ratios

PEG Ratio-0.86

Price to Book (P/B)0.99

Price to Sales (P/S)1.29

P/FCF Ratio-41.08

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage / Strong Balance SheetVery low leverage and a steadily expanding equity base reduce solvency risk and give the company durable financial headroom. This allows TTK Healthcare to fund operations, invest in capex or brands, and access capital on favorable terms while absorbing cyclical shocks.

Diversified Healthcare Product PortfolioA multi-segment portfolio spanning prescription, OTC and consumer health provides structural resilience. Diversification lowers reliance on any single product or channel, supports cross-selling, and preserves branded margin potential even if one segment slows.

History Of Revenue Growth And Positive MarginsSustained revenue growth historically and consistent mid-to-high single-digit net margins indicate the business can earn profits at scale. This track record supports the potential for margin recovery and cash generation once working-capital dynamics normalize.

Bears Say

Sustained Negative Operating And Free Cash FlowMulti-year cash burn erodes liquidity and undermines financial flexibility despite low debt. Persistent negative operating and free cash flow forces reliance on internal reserves or external funding, constraining reinvestment, dividends, and resilience to further downturns.

Recent Sharp Margin DeclineA notable drop in gross profit and EBITDA margin suggests structural cost or mix pressures. If persistent, weaker margins reduce internal cash generation and reinvestment capacity, making competitive positioning and long-term earnings less predictable.

Slowing Revenue Growth To Low-single DigitsDecelerating top-line growth limits operating leverage and the ability to offset margin pressures through scale. Prolonged low-single-digit growth raises execution risk for product launches and weakens returns on investments in brands and distribution expansion.

TTK Healthcare Limited News

TTK Healthcare Shareholder Declares Nil Holding Under SEBI Takeover Rules

The latest announcement is out from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ). TTK Healthcare Limited disclosed that shareholder...

2M ago

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

6M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹737.00 and its highest was ₹1402.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹12.68B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is Jul 30, 2026 which is in 46 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on May 30, 2026. The company reported ₹15.4 earnings per share for the quarter, beating the consensus estimate of N/A by ₹15.4.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.95%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹15.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.839%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals division provides a range of herbal and allopathic formulations. Within consumer products, the company is responsible for marketing and distributing items such as Woodward's Gripewater, the EVA cosmetics line, and Good Home scrubbers and air fresheners. Its medical devices segment manufactures and supplies artificial heart valves, in addition to developing orthopedic implants and surgical instruments. Furthermore, TTK Healthcare produces and markets protective devices, including male contraceptives. The food segment specializes in manufacturing and selling processed food items like potato and cereal-based pellets. Notably, the company also engages in map and atlas printing and publishing through its 'Others' segment. Founded in 1958 and headquartered in Chennai, India, TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.